title: Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of Infection.
abstract: Production of pro-inflammatory cytokines by innate immune cells at the early stages of bacterial infection is important for host protection against the pathogen. Many intracellular bacteria, including Francisella tularensis, the agent of tularemia, utilize the anti-inflammatory cytokine IL-10, to evade the host immune response. It is well established that IL-10 has the ability to inhibit robust antigen presentation by dendritic cells and macrophages, thus suppressing the generation of protective immunity. The pathogenesis of F. tularensis is not fully understood, and research has failed to develop an effective vaccine to this date. In the current study, we hypothesized that F. tularensis polarizes antigen presenting cells during the early stages of infection towards an anti-inflammatory status characterized by increased synthesis of IL-10 and decreased production of IL-12p70 and TNF-α in an IFN-ɣ-dependent fashion. In addition, F. tularensis drives an alternative activation of alveolar macrophages within the first 48 hours post-infection, thus allowing the bacterium to avoid protective immunity. Furthermore, we demonstrate that targeting inactivated F. tularensis (iFt) to Fcγ receptors (FcɣRs) via intranasal immunization with mAb-iFt complexes, a proven vaccine strategy in our laboratories, reverses the anti-inflammatory effects of the bacterium on macrophages by down-regulating production of IL-10. More specifically, we observed that targeting of iFt to FcγRs enhances the classical activation of macrophages not only within the respiratory mucosa, but also systemically, at the early stages of infection. These results provide important insight for further understanding the protective immune mechanisms generated when targeting immunogens to Fc receptors.
authors.affiliation: Department of Biological Sciences, Seton Hall University, South Orange, New Jersey, United States of America.
authors.forename: Zulfia
authors.initials: Z
authors.lastname: Babadjanova
authors.affiliation: Department of Biological Sciences, Seton Hall University, South Orange, New Jersey, United States of America.
authors.forename: Kari
authors.initials: K
authors.lastname: Wiedinger
authors.affiliation: Department of Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America.
authors.forename: Edmund J
authors.initials: EJ
authors.lastname: Gosselin
authors.affiliation: Department of Biological Sciences, Seton Hall University, South Orange, New Jersey, United States of America.
authors.forename: Constantine
authors.initials: C
authors.lastname: Bitsaktsis
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology*; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D005604:Francisella tularensis / Q000276:immunology*; D018836:Inflammation Mediators / Q000378:metabolism; D008168:Lung / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008262:Macrophage Activation / Q000276:immunology; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D011961:Receptors, Fc / Q000378:metabolism*; D017452:Receptors, IgG / Q000378:metabolism; D014406:Tularemia / Q000276:immunology* / Q000378:metabolism* / Q000382:microbiology
chemical_list: D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D000942:Antigens, Bacterial; D016207:Cytokines; D018836:Inflammation Mediators; D011961:Receptors, Fc; D017452:Receptors, IgG